Mirvetuximab soravtansine (ADC)
Mirvetuximab soravtansine is an ADC consisting of an FRA-directed antibody and DM4 used for the study of ovarian cancer and other FRα-positive cancers.
Product Specifications
Product Name Alternative
ELAHERE, huFR107-SPDB-DM4
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881081-100 1x 100 µL
CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940040-100 1x 100 µL
CD35 / CR1 (E11), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680495-100 1x 100 µL
SUMO-1 (SM1/495), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401783-100 1x 100 µL
CD45RB (B-Cell Marker) (PTPRC/1783R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details